These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19208829)

  • 1. A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention.
    Jordan VC
    Cancer Res; 2009 Feb; 69(4):1243-54. PubMed ID: 19208829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.
    Singh PB; Matanhelia SS; Martin FL
    Eur J Cancer; 2008 May; 44(7):928-36. PubMed ID: 18381236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
    Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
    Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers.
    Rau KM; Kang HY; Cha TL; Miller SA; Hung MC
    Endocr Relat Cancer; 2005 Sep; 12(3):511-32. PubMed ID: 16172190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dual effects of androgens on mammary gland].
    Brettes JP; Mathelin C
    Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway.
    Pandini G; Genua M; Frasca F; Vigneri R; Belfiore A
    Ann N Y Acad Sci; 2009 Feb; 1155():263-7. PubMed ID: 19250214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormones and carcinogenesis of the prostate: the role of estrogens.
    Ricke WA; Wang Y; Cunha GR
    Differentiation; 2007 Nov; 75(9):871-82. PubMed ID: 17924963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal implications in the development and treatment of prostate cancer.
    Ip C; Hall SJ
    Endocrinol Metab Clin North Am; 2007 Jun; 36(2):421-34. PubMed ID: 17543727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological mechanism of action and development of anti-steroid hormones].
    Oh-ishi S
    Nihon Rinsho; 1994 Mar; 52(3):679-84. PubMed ID: 8164367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy.
    Jordan VC; Ponder BA
    Breast Cancer Res; 2003; 5(6):281-3. PubMed ID: 14580241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel secondary hormonal therapy in advanced prostate cancer: an update.
    Van Allen EM; Ryan CJ
    Curr Opin Urol; 2009 May; 19(3):315-21. PubMed ID: 19342958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hormonal manipulations in prostate cancer.
    Ryan CJ
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):925-34. PubMed ID: 16861123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory models of breast and endometrial cancer to develop strategies for antiestrogen therapy.
    O'Regan RM; England GM; Macgregor JI; Yao KA; Muenzner HD; Takei H; Jordan VC
    Breast Cancer; 1998; 5(3):211-7. PubMed ID: 18841334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prospects for the control of cancer through screening-1976-today-the future.
    Berlin NI
    Trans Am Clin Climatol Assoc; 2004; 115():221-32; discussion 232. PubMed ID: 17060969
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.
    Spears M; Bartlett J
    Expert Opin Ther Targets; 2009 Jun; 13(6):665-74. PubMed ID: 19456271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line endocrine management: anti-androgens and anti-estrogens.
    de Voogt HJ
    Prog Clin Biol Res; 1985; 185A():351-7. PubMed ID: 3898134
    [No Abstract]   [Full Text] [Related]  

  • 18. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century.
    McGrath KG
    Med Hypotheses; 2009 Jun; 72(6):665-74. PubMed ID: 19307063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
    Harris RE
    Inflammopharmacology; 2009 Apr; 17(2):55-67. PubMed ID: 19340409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
    Huggins C; Hodges CV
    J Urol; 2002 Feb; 167(2 Pt 2):948-51; discussion 952. PubMed ID: 11905923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.